Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Surgery for moyamoya disease is offered to prevent neurologic deterioration from strokes. Two types of surgical approaches are offered for patients with moyamoya: direct and indirect revascularization.
Moyamoya surgical procedures requires approximately three days of hospitalization. Post-operatively, patients experience some minor scalp pain from the incision, and some patients may get headaches. Patients with moyamoya have minimal restrictions after surgery.
Moyamoya, a rare cerebrovascular disease, threatened Tara MacInnes' future. Neurosurgery expertise meant no more strokes and a return to the activities she loves.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
For your convenience, you may check in for all same-day appointments at the Stanford Neuroscience Health Center through a centralized, check-in desk near the front lobby. In addition to all outpatient services, you also can access onsite pre-surgery consultations at the center.
Call us at 650-723-5575 to make an appointment or send a fax to 650-723-1948.
Stanford Health Care provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.
HOW TO REFER
Call us at 650-723-5575 to refer a patient. Mail films for review to:
Gary Steinberg, MD, PhD
Dept. of Neurosurgery
300 Pasteur Drive, Room R-281
Stanford, CA 94305-5327
Track your patients' progress and communicate with Stanford providers securely online.